Chaim Hurvitz - Director at NRX Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
NRXP, NRXPW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Chaim Hurvitz since 9/19/2023

Holdings reported by Chaim Hurvitz for NRX Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.001 per share 1.44M $459K $0.32 Aug 30, 2023 By Shirat HaChaim Ltd.
Common Stock, par value $0.001 per share 570K $182K $0.32 Aug 30, 2023 Direct
Common Stock, par value $0.001 per share 208K $66.7K $0.32 Aug 30, 2023 By CH Health-Private Venture Capital Ltd.
Employee Stock Option 381K Oct 21, 2022 Direct Common Stock

Transactions reported by Chaim Hurvitz for NRX Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.